Search - tctmd.com

Displaying 721 - 740 of 1102

Sort: Relevancy | Date

News Daily News

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Caitlin E. Cox

April 28, 2017

News Daily News

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

Yael L. Maxwell

April 17, 2017

Presentation Fellows 2017

PCI for Bifurcations: What You Need to Know

Presenter: Emmanouil S. Brilakis, Manish A. Parikh

April 08, 2017

Presentation Fellows 2017

Left Main Disease: PCI vs CABG

Presenter: Emmanouil S. Brilakis, David E. Kandzari

April 08, 2017

Presentation Fellows 2017

Essentials of Clinical Trial Design: Statistics 101 for the Budding Interventionalist

Presenter: Sahil A. Parikh, David J. Cohen

April 08, 2017

News Daily News

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Todd Neale

April 04, 2017

Presentation ECHO 2017

Cardiac Transplant: The Role of Echo

Presenter: Michael H. Picard

April 01, 2017

Presentation ACC 2017

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

Presenter: Magnus Ohman

March 27, 2017

Presentation CHIP Washington DC 2017

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Presenter: Gregg W. Stone

March 21, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

Presentation CHIP Washington DC 2017

PCI of High-Risk Patients Under Hemodynamic Support: For Whom and With What?

Presenter: Robert W. Yeh

March 16, 2017

Presentation CHIP Washington DC 2017

The Importance of Coronary Calcification in Complex PCI: Data and Devices

Presenter: Ajay J. Kirtane

March 16, 2017

News Daily News

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Michael O'Riordan

March 16, 2017

Presentation CHIP Washington DC 2017

Status Update: The CHIP Initiative 2017

Presenter: Jeffrey W. Moses

March 16, 2017

News Daily News

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Michael O'Riordan

March 15, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Caitlin E. Cox

March 10, 2017

Presentation SIF 2017

Advancing the Guidelines for Unprotected Left Main PCI

Presenter: David A. Cox

March 10, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

L.A. McKeown

March 01, 2017

News Daily News

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

L.A. McKeown

February 27, 2017

Advertisement

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

PCI for Bifurcations: What You Need to Know

Left Main Disease: PCI vs CABG

Essentials of Clinical Trial Design: Statistics 101 for the Budding Interventionalist

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Cardiac Transplant: The Role of Echo

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

PCI of High-Risk Patients Under Hemodynamic Support: For Whom and With What?

The Importance of Coronary Calcification in Complex PCI: Data and Devices

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Status Update: The CHIP Initiative 2017

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Advancing the Guidelines for Unprotected Left Main PCI

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content